Luca Guerra

Associate Professor

University of Milano-Bicocca

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Luca Guerra is an Associate Professor at the University of Milano-Bicocca in Italy. His research focuses on medical imaging, particularly in relation to lymphoma and lung cancer, with significant contributions to understanding the prognostic value of metabolic imaging and PET in these diseases. Recent publications include studies on the role of metabolic tumor volume and interim PET as prognostic factors in lymphoma, as well as the application of advanced imaging technologies in clinical settings.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Francesco Dondi

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

ITALY

View details

Emanuele Angelucci

Hematology and Transpalnt Center Head

Ospedale Policlinico San Martino

ITALY

View details

Alessandra Tucci

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

ITALY

View details

Davide Paolo Bernasconi

University of Milano-Bicocca

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Luca Guerra

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi

Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma?

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub‐Study of the <scp>FOLL12</scp> Trial

Diagnostic Reference Levels in nuclear medicine for Positron Emission Tomography examinations: First Italian multicenter data collection

End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial

18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?

Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification

Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience

Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement?

Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions

Collaborators (4)

Francesco Dondi

Emanuele Angelucci

Alessandra Tucci

Davide Paolo Bernasconi

Make your next move.